This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
autonomous-vehicles: Archive
Lithia Motors Q4 Earnings Miss Expectations, Revenues Remain Flat Y/Y
by Zacks Equity Research
LAD posts Q4 EPS of $6.74 on $9.2B revenues, with new vehicle sales down but used cars and aftersales up.
FNegative Net Change LADNegative Net Change MODNegative Net Change PHINNegative Net Change
auto-tires-trucks autonomous-vehicles earnings
Mag 7 AI Arms Race: Heavy Capex, FCF Strain and One Clear Winner
by Rimmi Singhi
NVIDIA emerges as the clear winner as Big Tech's massive AI capex surge strains FCF, lifts debt, and reshapes Mag 7 balance sheets.
AMZNPositive Net Change AAPLNegative Net Change MSFTNegative Net Change NVDANegative Net Change TSLANegative Net Change GOOGLPositive Net Change METANegative Net Change
artificial-intelligence automation autonomous-vehicles cloud-computing electric-vehicles semiconductor tech-stocks
Will NIO's Recall Spark Broader Software Scrutiny in EVs?
by Ashish Singh
NIO recalls 246,229 EVs in China due to a software glitch that can black out screens, highlighting safety risks and OTA fixes.
FNegative Net Change TMNegative Net Change NIONegative Net Change
auto-tires-trucks autonomous-vehicles
Can NIO Monetize Its 100M Battery Swap Milestone in 2026?
by Ashish Singh
NIO hits 100M battery swaps, delivering 5.28B kWh and big cost savings as it ramps up to 1,000 new stations in 2026. Can the model pay off?
FNegative Net Change TSLANegative Net Change NIONegative Net Change
auto-tires-trucks autonomous-vehicles
W&T Offshore (WTI) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
WTIPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
AutoNation's Q4 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
AutoNation's Q4 EPS beats estimates as profits rise 2%, but revenues fall to $6.93B, missing forecasts amid weaker new-vehicle sales.
FNegative Net Change ANNegative Net Change MODNegative Net Change PHINNegative Net Change
auto-tires-trucks autonomous-vehicles earnings
Should You Buy Avnet (AVT) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
AVTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
RB Global (RBA) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
RBANegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Asbury Q4 Earnings Miss Expectations, Revenues Rise Y/Y
by Zacks Equity Research
ABG Q4 EPS misses estimates as revenues rise nearly 4% Y/Y, with weaker gross profit in new vehicle sales.
FNegative Net Change ABGNegative Net Change MODNegative Net Change PHINNegative Net Change
auto-tires-trucks autonomous-vehicles earnings
O'Reilly Q4 Earnings Miss Expectations, Revenues Rise Y/Y
by Zacks Equity Research
ORLY Q4 earnings miss estimates, but revenues rise 7.8% Y/Y as comparable sales grow 5.6% and store count hits 6,585.
FNegative Net Change ORLYPositive Net Change MODNegative Net Change PHINNegative Net Change
auto-tires-trucks autonomous-vehicles earnings